Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lybridos pharmacokinetic crossover study in healthy premenopausal women
NL-OMON37493Active, not recruiting
- Sponsor
- Clinical Research Organisations
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Lybridos, testosterone and buspirone in hypoactive sexual desire disorder (HSDD) and sexual dysfunction (2 arms), sponsored by Clinical Research Organisations. Primary endpoints: Cmax of total testosterone, Cmax of free testosterone and 4 more. Started Jul 2012; status: active, not recruiting.
02
Drugs
Lybridostestosteronebuspirone
03
Conditions
hypoactive sexual desire disorder (HSDD)sexual dysfunction
Beyond the preview
Go deeper on NL-OMON37493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37493.